Cargando…

SLP-2: a potential new target for improving mitochondrial function in Parkinson's disease

Detalles Bibliográficos
Autores principales:	Zanon, Alessandra, Hicks, Andrew A., Pramstaller, Peter P., Pichler, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649460/ https://www.ncbi.nlm.nih.gov/pubmed/29089985 http://dx.doi.org/10.4103/1673-5374.215251

Ejemplares similares

Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson's Disease Penetrance
por: Zanon, Alessandra, et al.
Publicado: (2018)

Interaction of Alpha-Synuclein With Lipids: Mitochondrial Cardiolipin as a Critical Player in the Pathogenesis of Parkinson’s Disease
por: Gilmozzi, Valentina, et al.
Publicado: (2020)

A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson’s disease by highlighting the use of cybrid models
por: Lang, Martin, et al.
Publicado: (2022)

Sigma-1 receptor: a potential new target for Parkinson's disease?
por: Francardo, Veronica
Publicado: (2014)

Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers
por: Castelo Rueda, Maria Paulina, et al.
Publicado: (2023)

Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson’s disease blood samples
por: Serafin, Alice, et al.
Publicado: (2014)

Crosstalk of organelles in Parkinson’s disease – MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes
por: Lang, Martin, et al.
Publicado: (2022)

Gut microbiota: a potential therapeutic target for Parkinson’s disease
por: Baizabal-Carvallo, José Fidel
Publicado: (2020)

Slp1 and Slp2-a Localize to the Plasma Membrane of CTL and Contribute to Secretion from the Immunological Synapse
por: Holt, Oliver, et al.
Publicado: (2008)

Functional Screening of Parkinson’s Disease Susceptibility Genes to Identify Novel Modulators of α-Synuclein Neurotoxicity in Caenorhabditis elegans
por: Vozdek, Roman, et al.
Publicado: (2022)

Genetics provides new individualized therapeutic targets for Parkinson’s disease
por: Garcia, Eric Joshua, et al.
Publicado: (2020)

Update on the management of restless legs syndrome: existing and emerging treatment options
por: Facheris, Maurizio F, et al.
Publicado: (2010)

Mitochondrial homeostasis in Parkinson’s disease - a triumvirate rule?
por: Ng, Chee-Hoe, et al.
Publicado: (2017)

Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
por: Pozo Devoto, Victorio M., et al.
Publicado: (2017)

Parkin Interacts with Apoptosis-Inducing Factor and Interferes with Its Translocation to the Nucleus in Neuronal Cells
por: Guida, Marianna, et al.
Publicado: (2019)

Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson’s Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study
por: Picca, Anna, et al.
Publicado: (2019)

A new hypothesis for Parkinson’s disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics
por: Obergasteiger, Julia, et al.
Publicado: (2018)

Generation of hiPSC-Derived Functional Dopaminergic Neurons in Alginate-Based 3D Culture
por: Gilmozzi, Valentina, et al.
Publicado: (2021)

Slp-coated liposomes for drug delivery and biomedical applications: potential and challenges
por: Luo, Gan, et al.
Publicado: (2019)

Potential role of biofeedback therapy for Parkinson’s disease
por: Kotani, Naoya, et al.
Publicado: (2021)

Cellular response against cytosolic leakage of mitochondrial DNA: insights into the pathology of Parkinson’s disease
por: Sakai, Akiko, et al.
Publicado: (2022)

Treadmill training in Parkinson’s disease: possible role of prefrontal modifications in the improved cortical-subcortical network function
por: Ding, Hao, et al.
Publicado: (2023)

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease
por: König, Eva, et al.
Publicado: (2021)

Profiling of Parkin-Binding Partners Using Tandem Affinity Purification
por: Zanon, Alessandra, et al.
Publicado: (2013)

Targeting chaperone-mediated autophagy for Parkinson’s disease therapy
por: Wang, Yi-Ting, et al.
Publicado: (2023)

A central role for mitochondrial-derived vesicles in the innate immune response: implications for Parkinson’s disease
por: Ryan, Thomas A., et al.
Publicado: (2021)

Insights into the Membrane Interactions of the Saposin-Like Proteins Na-SLP-1 and Ac-SLP-1 from Human and Dog Hookworm
por: Willis, Charlene, et al.
Publicado: (2011)

The inherent high vulnerability of dopaminergic neurons toward mitochondrial toxins may contribute to the etiology of Parkinson's disease
por: Wimalasena, Kandatege
Publicado: (2016)

Exploring the contribution of the mitochondrial disulfide relay system to Parkinson’s disease: the PINK1/CHCHD4 interplay
por: Arena, Giuseppe, et al.
Publicado: (2021)

Frequency of Heterozygous Parkin (PRKN) Variants and Penetrance of Parkinson's Disease Risk Markers in the Population-Based CHRIS Cohort
por: Castelo Rueda, Maria Paulina, et al.
Publicado: (2021)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Gene therapy in Parkinson's disease: targeting the endplasmic reticulum proteostasis network
por: Castillo, Valentina, et al.
Publicado: (2015)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

The coordinated regulation of mitochondrial structure and function by Drp1 for mitochondrial quality surveillance
por: Cho, Hyo Min, et al.
Publicado: (2019)

Dorsal root ganglion – a potential new therapeutic target for neuropathic pain
por: Sapunar, Damir, et al.
Publicado: (2012)

Structural and functional differences between the H-2 controlled Ss and Slp proteins
Publicado: (1978)

El Valle del Maíz, S.L.P. /
por: Montejano y Aguiñaga, Rafael, 1919-2000
Publicado: (1989)

Molecular mechanisms underlying the evolution of the slp76 signalosome
por: Qu, Xuemei, et al.
Publicado: (2017)

Expression and clinical significance of SLP-2 in ovarian tumors
por: Zhang, Jingjing, et al.
Publicado: (2019)

The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation
por: Gerke, Christiane, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_l748r2rq9sv25uqo6ubtv22852